The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis

被引:86
|
作者
Demidov, O. N.
Kek, C.
Shreeram, S.
Timofeev, O.
Fornace, A. J.
Appella, E.
Bulavin, D. V.
机构
[1] Natl Univ Singapore, Inst Mol & Cell Biol, Cell Cycle Control & Tumorigenesis Grp, Singapore 138673, Singapore
[2] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Wip1; phosphatase; p38; MAPK; MKK6; breast cancer; ErbB2; proliferation; MMTV;
D O I
10.1038/sj.onc.1210032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is increasing evidence for the role of wild-type p53 induced phosphatase 1( Wip1) phosphatase in the regulation of tumorigenesis. To evaluate Wip1 as a breast cancer oncogene, we generated a mouse strain with targeted expression of Wip1 to the breast epithelium. We found that these mice are prone to cancer when intercrossed with transgenics expressing the ErbB2 oncogene but not conditional knockouts for Brca2. This tumor-prone phenotype of Wip1 is fully eliminated through attenuation of proliferation by activating the MKK6/p38 mitogen-activated protein kinases ( MAPK) cascade in mice bearing a constitutively active form of MKK6. We propose that Wip1 phosphatase operates within the MKK6/p38 MAPK signaling pathway to promote ErbB2-driven mammary gland tumorigenesis.
引用
收藏
页码:2502 / 2506
页数:5
相关论文
共 50 条
  • [1] The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis
    O N Demidov
    C Kek
    S Shreeram
    O Timofeev
    A J Fornace
    E Appella
    D V Bulavin
    [J]. Oncogene, 2007, 26 : 2502 - 2506
  • [2] Regulation of glucose transporter expression by MKK6/3 and p38 MAPK pathway activation
    Fujishiro, M
    Gotoh, Y
    Katagiri, H
    Sakoda, H
    Kikuchi, M
    Asano, T
    [J]. DIABETES, 2001, 50 : A282 - A282
  • [3] Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer
    Stramucci, Lorenzo
    Pranteda, Angelina
    Bossi, Gianluca
    [J]. CANCERS, 2018, 10 (05)
  • [4] MKK6 is required for TNFα production in a P38 pathway-dependent manner in THP1 cells
    Han, ZN
    Sun, W
    Zhang, S
    Parker, A
    Yabkowitz, R
    Jupp, R
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S113 - S113
  • [5] Role of C/EBP-β, p38 MAPK, and MKK6 in IL-1β-Mediated C3 Gene Regulation in Astrocytes
    Maranto, Jeffrey
    Rappaport, Jay
    Datta, Prasun K.
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2011, 112 (04) : 1168 - 1175
  • [6] MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression
    Fujishiro, M
    Gotoh, Y
    Katagiri, H
    Sakoda, H
    Ogihara, T
    Anai, M
    Onishi, Y
    Ono, H
    Funaki, M
    Inukai, K
    Fukushima, Y
    Kikuchi, M
    Oka, Y
    Asano, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) : 19800 - 19806
  • [7] Agonist-induced platelet activation is regulated by ASK1 through MKK6/P38 kinase pathway
    Naik, U. P.
    Turaga, R.
    Ichijo, H.
    Naik, M. U.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 770 - 770
  • [8] Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK–mediated activation of the p16Ink4a-p19Arf pathway
    Dmitry V Bulavin
    Crissy Phillips
    Bonnie Nannenga
    Oleg Timofeev
    Larry A Donehower
    Carl W Anderson
    Ettore Appella
    Albert J Fornace
    [J]. Nature Genetics, 2004, 36 : 343 - 350
  • [9] Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16Ink4a-p19Arf pathway
    Bulavin, DV
    Phillips, C
    Nannenga, B
    Timofeev, O
    Donehower, LA
    Anderson, CW
    Appella, E
    Fornace, AJ
    [J]. NATURE GENETICS, 2004, 36 (04) : 343 - 350
  • [10] Overexpression of wild-type p53 induced phosphatase (Wip1) abrogates p38 MAPK-p53-Wip1 pathway, contributing to the tumorigenesis of human breast cancers
    Yu, E
    Aim, Y
    Yoon, HS
    Gong, G
    Choi, J
    [J]. LABORATORY INVESTIGATION, 2006, 86 : 295A - 295A